Co-Diagnostics, Inc. Realized Investment Gains (Losses)
Co-Diagnostics, Inc. (CODX) reported Realized Investment Gains (Losses) of $683.37 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:RealizedInvestmentGainsLosses · last filed 2026-08-13
- Co-Diagnostics, Inc. realized investment gains (losses) for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- Co-Diagnostics, Inc. realized investment gains (losses) for the quarter ending 2025-09-30 was $41.54K, a 85.83% decline year-over-year.
- Co-Diagnostics, Inc. realized investment gains (losses) for the quarter ending 2025-06-30 was $340.36K, a 358.92% increase year-over-year.
- Co-Diagnostics, Inc. realized investment gains (losses) for the quarter ending 2025-03-31 was $301.46K, a 32.18% increase year-over-year.
- Co-Diagnostics, Inc. realized investment gains (losses) for fiscal 2025 was $683.37K, a 21.52% decline from fiscal 2024.
- Co-Diagnostics, Inc. realized investment gains (losses) for fiscal 2024 was $870.75K, a 61.18% decline from fiscal 2023.
- Co-Diagnostics, Inc. realized investment gains (losses) for fiscal 2023 was $2.24M.
| Period end | Realized Investment Gains (Losses) 3 month | Realized Investment Gains (Losses) 6 month | Realized Investment Gains (Losses) 9 month | Realized Investment Gains (Losses) 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $41.54K derived: sum of 2 quarters · filed 2026-03-31 | $381.90K derived: sum of 3 quarters · filed 2026-08-13 | $683.37K 10-K · filed 2026-03-31 |
| 2025-09-30 | $41.54K 10-Q · filed 2025-11-13 | $381.90K derived: sum of 2 quarters · filed 2026-08-13 | $683.37K 10-Q · filed 2025-11-13 | $958.81K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $340.36K 10-Q · filed 2026-08-13 | $641.82K 10-Q · filed 2026-08-13 | $917.27K derived: sum of 3 quarters · filed 2026-08-13 | $1.21M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $301.46K 10-Q · filed 2026-05-14 | $576.91K derived: sum of 2 quarters · filed 2026-05-14 | $869.98K derived: sum of 3 quarters · filed 2026-05-14 | $944.14K derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | $275.44K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $568.51K derived: sum of 2 quarters · filed 2026-03-31 | $642.67K derived: sum of 3 quarters · filed 2026-03-31 | $870.75K 10-K · filed 2026-03-31 |
| 2024-09-30 | $293.07K 10-Q · filed 2025-11-13 | $367.23K derived: sum of 2 quarters · filed 2025-11-13 | $595.30K 10-Q · filed 2025-11-13 | $1.58M derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | $74.17K 10-Q · filed 2025-08-14 | $302.24K 10-Q · filed 2025-08-14 | $1.29M derived: sum of 3 quarters · filed 2025-08-14 | $1.72M derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $228.07K 10-Q · filed 2025-05-08 | $1.22M derived: sum of 2 quarters · filed 2025-05-08 | $1.64M derived: sum of 3 quarters · filed 2025-05-08 | $2.05M derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | $988.34K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $1.41M derived: sum of 2 quarters · filed 2025-03-27 | $1.82M derived: sum of 3 quarters · filed 2025-03-27 | $2.24M 10-K · filed 2025-03-27 |
| 2023-09-30 | $425.45K 10-Q · filed 2024-11-07 | $836.64K derived: sum of 2 quarters · filed 2024-11-07 | $1.25M 10-Q · filed 2024-11-07 | |
| 2023-06-30 | $411.19K 10-Q · filed 2024-08-08 | $829.27K 10-Q · filed 2024-08-08 | ||
| 2023-03-31 | $418.08K 10-Q · filed 2024-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| ALLURION TECHNOLOGIES, INC. (ALUR) | United States | $0.010B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |